{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:05:58Z","timestamp":1790899558777,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ymgme.2008.02.005","type":"journal-article","created":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T13:31:56Z","timestamp":1207143116000},"page":"204-211","source":"Crossref","is-referenced-by-count":77,"title":["Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis"],"prefix":"10.1016","volume":"94","author":[{"given":"Elena","family":"Elliot-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneliese O.","family":"Speak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emyr","family":"Lloyd-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarnoud C. van der","family":"Spoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylvaganam","family":"Jeyakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry D.","family":"Butters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A.","family":"Dwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"d\u2019Azzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.02.005_bib1","series-title":"Lysosomal Disorders of the Brain","first-page":"81","article-title":"Primary defects in lysosomal enzymes","author":"Winchester","year":"2004"},{"key":"10.1016\/j.ymgme.2008.02.005_bib2","series-title":"Lysosomal Disorders of the Brain","first-page":"50","article-title":"Clinical aspects and diagnosis","author":"Wraith","year":"2004"},{"key":"10.1016\/j.ymgme.2008.02.005_bib3","series-title":"Lysosomal Disorders of the Brain","first-page":"381","article-title":"Inhibition of substrate synthesis: a pharmacological approach for glycosphingolipid storage disease therapy","author":"Platt","year":"2004"},{"key":"10.1016\/j.ymgme.2008.02.005_bib4","series-title":"Lysosomal Disorders of the Brain","first-page":"327","article-title":"Enzyme replacement therapy","author":"Neufeld","year":"2004"},{"key":"10.1016\/j.ymgme.2008.02.005_bib5","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-Butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.02.005_bib6","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","article-title":"N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.02.005_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2004.04.012","article-title":"Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease","volume":"16","author":"Andersson","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2008.02.005_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI5542","article-title":"A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder","volume":"103","author":"Liu","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2008.02.005_bib9","first-page":"472","article-title":"Miglustat. Oxford GlycoSciences\/Actelion","volume":"4","author":"Lachmann","year":"2003","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ymgme.2008.02.005_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/13543784.10.3.455","article-title":"Substrate reduction therapy for glycosphingolipid storage disorders","volume":"10","author":"Lachmann","year":"2001","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.ymgme.2008.02.005_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","article-title":"N-Butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo","volume":"59","author":"Andersson","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2008.02.005_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/6.2.205","article-title":"Generalized CNS disease and massive G(M1)-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase","volume":"6","author":"Hahn","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2008.02.005_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"Beta-galactosidase-deficient mouse as an animal model for G(M1)-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2008.02.005_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2008.02.005_bib15","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyakumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.02.005_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann\u2013Pick disease type C","volume":"11","author":"Zervas","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ymgme.2008.02.005_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1471-4159.2004.02381.x","article-title":"N-Butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis","volume":"89","author":"Kasperzyk","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2008.02.005_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M400411-JLR200","article-title":"Substrate reduction reduces gangliosides in postnatal cerebrum\u2013brainstem and cerebellum in GM1 gangliosidosis mice","volume":"46","author":"Kasperzyk","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2008.02.005_bib19","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1074\/jbc.272.31.19365","article-title":"Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin","volume":"272","author":"Platt","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.02.005_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-006-0473-y","article-title":"Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment","volume":"30","author":"Heare","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2008.02.005_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","article-title":"Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling","volume":"331","author":"Neville","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2008.02.005_bib22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/awg089","article-title":"Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis","volume":"126","author":"Jeyakumar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2008.02.005_bib23","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.1074\/jbc.M702387200","article-title":"Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis","volume":"282","author":"Walden","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2008.02.005_bib24","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1073\/pnas.95.11.6373","article-title":"Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease","volume":"95","author":"Chen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.02.005_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0300-9084(01)01308-6","article-title":"Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration","volume":"83","author":"Vyas","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.ymgme.2008.02.005_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1096-9861(19991025)413:3<429::AID-CNE6>3.0.CO;2-7","article-title":"Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development","volume":"413","author":"Zervas","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2008.02.005_bib27","doi-asserted-by":"crossref","first-page":"12459","DOI":"10.1073\/pnas.0500893102","article-title":"Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth","volume":"102","author":"Jennemann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.02.005_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/00498250601094543","article-title":"The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat","volume":"37","author":"Treiber","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ymgme.2008.02.005_bib29","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1073\/pnas.0400625101","article-title":"Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2008.02.005_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1463-1326.2006.00701.x","article-title":"N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice","volume":"10","author":"Priestman","year":"2008","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.ymgme.2008.02.005_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jnr.20798","article-title":"Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice","volume":"83","author":"Denny","year":"2006","journal-title":"J. Neurosci. Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T10:30:10Z","timestamp":1708770610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1096719208000504"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.02.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}